Jazz Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.

CEO

Bruce C. Cozadd

CEOBruce C. Cozadd

Employees

2,800

Employees2,800

Headquarters

Dublin, Dublin

HeadquartersDublin, Dublin

Founded

2005

Founded2005

Employees

2,800

Employees2,800

JAZZ Key Statistics

Market cap

6.79B

Market cap6.79B

Price-Earnings ratio

-16.61

Price-Earnings ratio-16.61

Dividend yield

—

Dividend yield—

Average volume

909.23K

Average volume909.23K

High today

$112.40

High today$112.40

Low today

$106.66

Low today$106.66

Open price

$107.67

Open price$107.67

Volume

1.60M

Volume1.60M

52 Week high

$148.06

52 Week high$148.06

52 Week low

$95.49

52 Week low$95.49

JAZZ News

Seeking Alpha 2d

Jazz Pharmaceuticals projects late Q4 zanidatamab Phase III data, signals leadership transition and updates 2025 guidance

Earnings Call Insights Jazz Pharmaceuticals projects late Q4 zanidatamab Phase III data, signals leadership transition and updates 2025 guidance Aug. 06, 2025 5...

Analyst ratings

95%

of 20 ratings

Buy

95%

Hold

Sell

People also own

Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.